EGFR TKIs - Globe Thesis

Keyword [EGFR TKIs] Result: 181 - 194 \| Page: 10 of 10
181.	Meta-analysis Of The Efficacy And Safety Of EGFR-TKIs Plus Bevacizumab Versus Egfr-tkis Alone In Non-small Cell Lung Cancer
182.	Observation On The Efficacy Of Osimertinib Combined With Anti-angiogenic Drugs In Advanced NSCLC Patients With T790M Mutation After First-generation EGFR-TKIs Resistance
183.	Effects And Mechanisms Of Extract Of Laminaria Japonica,Fucoxanthin And Eckol On Sensitizing Non-Small Cell Lung Cancer Cells To Gefitinib
184.	A Real World Study On EGFR Mutation Status And Prognostic Factors Of Non-small Cell Lung Cancer In Hainan
185.	Meta-analysis Of EGFR-TKIs Combined With Anti-vascular Targeting Drugs Versus EGFR-TKIs In The Treatment Of Advanced Non-small Cell Lung Cancer
186.	Correlation Analysis Of EGFR-TKIs Treatment Prognosis And T790M Mutation Status In Patients With Lung Cancer
187.	A-meta-analysis Of Neoadjuvant EGFR-TKIs And Neoadjuvant Chemotherapy For Patients With Non-small Cell Lung Cancer
188.	The Role Of Osimertinib Combined With PD0332991 In EGFR-TKIs Resistant Lung Cancer Cells
189.	Correlation Between EGFR Mutation Site And Abundance And Efficacy Of Targeted Drugs In Patients With Lung Adenocarcinoma
190.	The Impact Of Cocurrent Alterations On EGFR-TKIs Efficacy And Progression Patterns After Drug Resistance In Advanced EGFR-mutant NSCLC Patients
191.	Expression Of FEZF1-AS1 And AKT3 In Advanced Lung Adenocarcinoma And Their Relationship With The Efficacy Of EGFR-TKIs
192.	The Mechanisms Underlying The Synergistic Antitumor Activity Of Multi-targeted Tyrosine Kinase Inhibitor Famitinib And The Third-generation EGFR Inhibitor HS-10296 As Well As The Antitumor Activity Of The Novel Antibody-drug Conjugates Targeting CD79b
193.	Clinical Study On The Treatment Of Modified Xiaofeng Powder On EGFR-TKIs Related Adverse Skin Reactions Of Wind-heat Type
194.	Based On The Literature And Clinical Research, The Drug Rules Of Traditional Chinese Medicine Assisted EGFR-TKIs In The Treatment Of Lung Cancer Were Discussed
<<First <Prev Next> Last>> Jump to